United Therapeutics Corp
SWB:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
SWB:UTH
|
US |
|
S
|
SolGold PLC
F:S8F
|
AU |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
|
M
|
Marley Spoon Group SE
F:MS1
|
LU |
|
Premia Finance SpA Societa di Mediazione Creditizia
F:81U
|
IT |
|
Five Star Bancorp
F:4F6
|
US |
|
C
|
Comcast Corp
DUS:CTP2
|
US |
|
P
|
PharmaSGP Holding SE
F:PSG
|
DE |
|
Bushveld Minerals Ltd
F:23U
|
ZA |
|
B
|
Bank Central Asia Tbk PT
XMUN:BZG2
|
ID |
|
Kruk SA
F:83I
|
PL |
|
C
|
CDK Global Inc
F:C2G
|
US |
Shareholder Yield
Current shareholder yield for 
UTH is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
UTH Price
United Therapeutics Corp
| Average Annual Return | 25.47% |
| Standard Deviation of Annual Returns | 39.99% |
| Max Drawdown | -14% |
| Market Capitalization | 24B EUR |
| Shares Outstanding | 28 217 038 |
| Percentage of Shares Shorted |
N/A
|
